Hemophagocytic Lymphohistiocytosis Activation Syndrome with Multi-Organ Co-Infections: A Therapeutic Dilemma

Authors

  • Shivangi Gohil, M.D. HCA Healthcare
  • Hannah Berrett, M.D., Ph.D. HCA Healthcare https://orcid.org/0000-0002-5018-2602
  • Rebecca Kurian, M.D. HCA Healthcare
  • Johnathon Phillips, M.D. HCA Healthcare
  • Mala Goyal, M.D. HCA Healthcare
  • Francis Dailey, M.D. HCA Healthcare

DOI:

https://doi.org/10.17161/kjm.vol16.20957

Keywords:

hemophagocytic lymphohistiocytosis, Tuberculosis, hepatitis A, COVID

Metrics

Metrics Loading ...

Downloads

Published

2023-10-30

Issue

Vol. 16 No. 3 (2023): Sept. - Dec.

Section

Case Reports

License

Copyright (c) 2023 Shivangi Gohil, M.D., Hannah Berrett, M.D., Ph.D., Rebecca Kurian, M.D., Johnathon Phillips, M.D., Mala Goyal, M.D., Francis Dailey, M.D.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Shivangi Gohil, Berrett, H., Kurian, R., Phillips, J., Goyal, M., & Dailey, F. (2023). Hemophagocytic Lymphohistiocytosis Activation Syndrome with Multi-Organ Co-Infections: A Therapeutic Dilemma. Kansas Journal of Medicine, 16(3), 268-270. https://doi.org/10.17161/kjm.vol16.20957